China Capital Management

Total investments

40

Average round size

28M

Portfolio companies

38

Rounds per year

2.67

Lead investments

5

Follow on index

0.05

Exits

1

Stages of investment
Private Equity
Areas of investment
LogisticsBiotechnologyBroadcastingRoboticsManufacturingMedicalSemiconductorElectronicsMedia and EntertainmentTV Production

Investments analytics

Analytics

Total investments
40
Lead investments
5
Exits
1
Rounds per year
2.67
Follow on index
0.05
Investments by industry
  • Manufacturing (12)
  • Semiconductor (6)
  • Robotics (4)
  • TV Production (3)
  • Broadcasting (3)
  • Show 62 more
Investments by region
  • China (40)
Peak activity year
2023

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
66M
Group Appearance index
0.88
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Huayi New Energy 28 Sep 2023 Commercial, Information Technology, Energy, Industrial, Machinery Manufacturing Early Stage Venture Xinjiang, Ürümqi, China
Ornim Medical 21 Aug 2012 Biotechnology, Health Care, Medical Device, Neuroscience Early Stage Venture 20M North District, Israel, Israel
Yi'an Holdings 01 Feb 2024 Early Stage Venture 309M Shanghai, Baoshan, China

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.